BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24254971)

  • 1. Expression of sclerostin scFv and the effect of sclerostin scFv on healing of osteoporotic femur fracture in rats.
    Yao Q; Ni J; Hou Y; Ding L; Zhang L; Jiang H
    Cell Biochem Biophys; 2014 Jun; 69(2):229-35. PubMed ID: 24254971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained-release of sclerostin single-chain antibody fragments using poly(lactic-co-glycolic acid) microspheres for osteoporotic fracture repair.
    Li M; Li S; Liu J; Cui X; Zhang S; Zhou J; Wang X; Yao Q
    J Biomed Mater Res A; 2019 Aug; 107(8):1832-1840. PubMed ID: 31012249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
    Li X; Ominsky MS; Warmington KS; Morony S; Gong J; Cao J; Gao Y; Shalhoub V; Tipton B; Haldankar R; Chen Q; Winters A; Boone T; Geng Z; Niu QT; Ke HZ; Kostenuik PJ; Simonet WS; Lacey DL; Paszty C
    J Bone Miner Res; 2009 Apr; 24(4):578-88. PubMed ID: 19049336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
    Li X; Ominsky MS; Niu QT; Sun N; Daugherty B; D'Agostin D; Kurahara C; Gao Y; Cao J; Gong J; Asuncion F; Barrero M; Warmington K; Dwyer D; Stolina M; Morony S; Sarosi I; Kostenuik PJ; Lacey DL; Simonet WS; Ke HZ; Paszty C
    J Bone Miner Res; 2008 Jun; 23(6):860-9. PubMed ID: 18269310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat Osteosarcoma Cells as a Therapeutic Target Model for Osteoregeneration via Sclerostin Knockdown.
    Sedaghati B; Jahroomishirazi R; Starke A; Hacker MC; Schulz-Siegmund M
    Cells Tissues Organs; 2016; 201(5):366-79. PubMed ID: 27233518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.
    Winkler DG; Sutherland MK; Geoghegan JC; Yu C; Hayes T; Skonier JE; Shpektor D; Jonas M; Kovacevich BR; Staehling-Hampton K; Appleby M; Brunkow ME; Latham JA
    EMBO J; 2003 Dec; 22(23):6267-76. PubMed ID: 14633986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
    Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
    J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro.
    Jäger A; Götz W; Lossdörfer S; Rath-Deschner B
    J Periodontal Res; 2010 Apr; 45(2):246-54. PubMed ID: 19778325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The osteoprotective effect of psoralen in ovariectomy-induced osteoporotic rats via stimulating the osteoblastic differentiation from bone mesenchymal stem cells.
    Yang Z; Huang JH; Liu SF; Zhao YJ; Shen ZY; Wang YJ; Bian Q
    Menopause; 2012 Oct; 19(10):1156-64. PubMed ID: 22781784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.
    Sutherland MK; Geoghegan JC; Yu C; Turcott E; Skonier JE; Winkler DG; Latham JA
    Bone; 2004 Oct; 35(4):828-35. PubMed ID: 15454089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
    Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
    J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of recombinant human bone morphogenetic protein 2 to enhance bone healing in the presence of tobramycin: evaluation in a rat segmental defect model.
    Glatt V; Kwong FN; Park K; Parry N; Griffin D; Vrahas M; Evans CH; Harris M
    J Orthop Trauma; 2009; 23(10):693-701. PubMed ID: 19858977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin antibody treatment enhances metaphyseal bone healing in rats.
    Agholme F; Li X; Isaksson H; Ke HZ; Aspenberg P
    J Bone Miner Res; 2010 Nov; 25(11):2412-8. PubMed ID: 20499342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element.
    Yu L; van der Valk M; Cao J; Han CY; Juan T; Bass MB; Deshpande C; Damore MA; Stanton R; Babij P
    Bone; 2011 Dec; 49(6):1131-40. PubMed ID: 21890009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease.
    Kramann R; Kunter U; Brandenburg VM; Leisten I; Ehling J; Klinkhammer BM; Knüchel R; Floege J; Schneider RK
    J Bone Miner Res; 2013 Dec; 28(12):2523-34. PubMed ID: 23703894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-2 induced early bone formation in spine fusion using rat ovariectomy osteoporosis model.
    Park SB; Park SH; Kim NH; Chung CK
    Spine J; 2013 Oct; 13(10):1273-80. PubMed ID: 23953506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin: a novel target for intervention in the treatment of osteoporosis.
    Lewiecki EM
    Discov Med; 2011 Oct; 12(65):263-73. PubMed ID: 22031665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
    Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
    J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.